MAPT and Alzheimer disease: In humans, patients with sporadic AD display longitudinal increases in tau when low levels of tau were detectable early in the disease course, but no differences (or increases) have been observed in tau in patients with high levels of tau at baseline (Kanai et al., 1998; Sunderland et al., 1999).